Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.

TJ, Bunch; S, Mahapatra; D, Murdock; J, Molden; JP, Weiss; HT, May; TL, Bair; KM, Mader; BG, Crandall; JD, Day; JS, Osborn; JB, Muhlestein; DL, Lappe; JL, Anderson

doi:10.1111/j.1540-8159.2011.03208.x

Public

Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.

Shared by NobleBlocks on Sep 3, 2011 • 12:00 AM UTC

Authors:

Bunch TJ

Mahapatra S

Murdock D

Abstract

Background There are limited options for patients who present with antiarrhythmic-drug (AAD)-refractory ventricular tachycardia (VT) with recurrent implantable cardioverter defibrillator (ICD) shocks. Ranolazine is a drug that exerts antianginal and antiischemic effects and also acts as an antiarrhy...

Discussions